Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family

JAMA

Volumn 275, Issue 6, 1996, Pages 452-457

  Bifani, Pablo J ^a   Plikaytis, Bonnie B ^c   Kapur, Vivek ^b,f   Stockbauer, Kathryn ^b   Pan, Xi ^b   Lutfey, Michael L ^a   Moghazeh, Soraya L ^a   Eisner, William ^a   Daniel, Thomas M ^e   Kaplan, Mark H ^d   Crawford, Jack T ^b   Musser, James M ^b   Kreiswirth, Barry N ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^d NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENETICS; BACTERIAL MUTATION; CLONE; HUMAN; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS; TUBERCULOSIS CONTROL; UNITED STATES;

EID: 13344286314     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.275.6.452     Document Type: Article

References (26)

1. Bloom BR, Murray CJL. Tuberculosis, commentary on a reemergent killer. Science. 1992;257:1055-1063.
2. Brudney K, Dobkin J. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness and the decline of tuberculosis control programs. Am Rev Respir Dis. 1991;144:745-749.
3. Frieden TR, Sterling T, Pablos-Mendez A, et al. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med. 1993;328:521-526.
4. Sepkowitz KA, Telzak EE, Recalde S, et al. Trends in the susceptibility of TB in New York City. Clin Infect Dis. 1994;18:755-759.
5. Bloch AB, Cauthen GM, Onorato IM, et al. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 1994;271:665-671.
6. Snider DE, Roper WL. The new tuberculosis. N Engl J Med. 1992;326:703-705.
7. Small PM, Moss A. Molecular epidemiology and the new tuberculosis. Infect Agents Dis. 1903;2:132-138.
8. Hopewell PC. Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management and control of tuberculosis. Clin Infect Dis. 1992;18:540-546.
9. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City: turning the tide. N Engl J Med. 1995;333:229-233.
10. Centers for Disease Control and Prevention. Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system - New York, 1991. MMWR Morbid Mortal Wkly Rep. 1992;41:507-509.
11. Horn DL, Hewlett D, Alfalla C, et al. Natural history and treatment outcome of 55 patients with rifampin-isoniazid-streptomycin-ethambutol (RISE)-resistant tuberculosis. Infect Dis Clin Pract. In press.
12. Coronado VG, Beck-Sague CM, Hutton MD, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis. 1993;168:1052-1055.
13. Valway SE, Greifinger EB, Papania M, et al. Multidrug-resistant tuberculosis in the New York State prison system, 1990-1991. J Infect Dis. 1994; 170:151-156.
14. van Embden JDA, Cave MD, Crawford JT, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993;31:406-409.
15. Kapur V, Li LL, Hamrick ME, et al. Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. Arch Pathol Lab Med. 1995;119:131-138.
16. Musser JM. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev. 1995;8:496-514.
17. Friedman CR, Stoeckle MY, Kreiswirth BN, et al. Transmission of multidrug-resistant tuberculosis in a large urban setting. Am J Respir Crit Care Med. 1995;152:355-359.
18. Siddiqi S. BACTEC TB Systems: Product and Procedure Manual. Sparks, Md: Becton Diekinson Co; 1989.
19. Antimycobacterial Susceptibility Testing: Proposed Standards. Villanova, Pa: National Committee for Clinical Laboratory Standards; 1990. NCCLS publication M24-P.
20. Ross BC, Raios K, Jackson K, et al. Molecular cloning of a highly repeated DNA element from Mycobactenum tuberculosis and its use as an epidemiological tool. J Clin Microbiol. 1992;30:942-946.
21. Plikaytis BB, Marden JL, Crawford JT, et al. Multiplex PCR assay specific for the multidrug-resistant strain W of Mycobacterium tuberculosis. J Clin Microbiol. 1994;32:1542-1546.
22. Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons-Florida and New York, 1988-1991. MMWR Morbid Mortal Wkly Rep. 1991; 40:585-591.
23. van Soohngen D, Hermans PWM, de Haas PEW, et al. Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J Clin Microbiol. 1991;29:2078-2586.
24. Hewlett D Jr, Horn DL, Franchini D, et al. A report of 91 health care workers with nosocomial tuberculosis infection following exposure to rifampin-isoniazid-streptomycin-ethambutol (RISE)-resistant and drug susceptible tuberculosis. Infect Dis Clin Pract. 1995;4:389-396.
25. Weis SE, Slocum PC, Biais FX, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med. 1994;330:1179-1184.
26. Longuet P, Pierre J, Lacassin F, et al. A limited multidrug-resistant Mycobacterium tuberculosis (MDR-TB) outbreak: screening of contact hospitalized patients (pts). In: Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy: September 17-20, 1995; San Francisco, Calif. Abstract J59.